India’s health-tech and neurotechnology ecosystem is witnessing a new wave of innovation as startups combine artificial intelligence, wearable technology, and wellness-focused experiences to build next-generation consumer products. In one of the most notable D2C startup news and D2C funding news developments in the emerging neurotech category, Gurugram and New York-based Sychedelic has raised $3.5 million (around ₹31.5 crore) in a seed funding round led by TurboStart, Ideabaaz, and Praveek Ventures, alongside angel investors from India, the UAE, and the NRI community.
The latest D2C funding rounds development highlights the increasing investor interest in technology-driven wellness startups that sit at the intersection of AI, healthcare, and consumer electronics. As India’s D2C ecosystem continues expanding rapidly, Sychedelic is positioning itself as a global innovation-led startup focused on mental wellness, neuroadaptive experiences, and wearable healthcare technology.
Founded by Ria Rustagi and Bhavya, Sychedelic is building what it describes as the world’s first closed-loop neuromodulation wearable in a headphone format designed for everyday use. The product combines neurostimulation, biometric tracking, and adaptive AI to monitor and respond to a user’s mental state in real time, reflecting some of the biggest D2C market trends 2025 around personalised wellness and AI-enabled healthcare experiences.
The startup plans to utilise the fresh capital for marketing, manufacturing scale-up, research expansion, and its upcoming global Kickstarter launch scheduled for May 2026. The funding also supports Sychedelic’s broader international expansion strategy as the company prepares to strengthen its presence across India and the United States.
Within India’s fast-growing D2C business India ecosystem, health-focused wearable technology is emerging as one of the most exciting categories for investors and consumers alike. Rising awareness around stress management, sleep optimisation, mental wellness, and productivity enhancement is creating strong consumer demand for technology-enabled wellness products. This shift is also contributing to the rapid rise of premium D2C brands India operating within the wellness and consumer technology sectors.
According to the company, the wearable integrates technologies such as transcranial direct current stimulation (tDCS), binaural beats, and HRV biofeedback to create personalised neuroadaptive experiences aimed at stress reduction, sleep support, focus enhancement, and overall mental wellness. This positions Sychedelic strongly within the growing global wellness technology market where consumers increasingly seek data-driven, personalised health solutions.
The company stated that more than 100 early adopters have already used the product over the last six months, helping refine the wearable’s hardware systems, stimulation technologies, and adaptive AI algorithms through real-world usage and feedback. This early traction demonstrates growing consumer curiosity around neuroscience-backed wellness products and reflects larger D2C consumer behavior India trends focused on self-care and preventive health.
In another major milestone, Sychedelic has secured approval from the Central Drugs Standard Control Organisation (CDSCO), giving the product medical device status in India. The company has also filed global patent applications, which are currently under patent-pending status, strengthening its intellectual property portfolio as it prepares for international expansion.
The rise of startups like Sychedelic also reflects how India’s D2C ecosystem India is evolving beyond traditional ecommerce into deep-tech innovation, AI-powered healthcare, and premium technology-led consumer experiences. Investors across VC-backed D2C brands and emerging wellness startups are increasingly backing companies that combine scalable technology with global market potential.
As D2C industry news increasingly focuses on sustainable innovation, premiumisation, and next-generation consumer experiences, Sychedelic’s funding round positions the startup among the latest D2C startups building globally relevant products from India. With strong investor backing, advanced wearable technology, medical-device recognition, and global expansion plans underway, the company is rapidly strengthening its position within the fast-growing digital wellness and neurotechnology ecosystem.
